1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Encorafenib plus cetuximab for previously treated BRAF V600E mutation-positive metastatic colorectal cancer

Technology appraisal guidance [TA668] Published date: 06 January 2021

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers PDF 3.87 MB 06 January 2021  
  • Final appraisal determination committee papers PDF 1.63 MB 06 January 2021